Dysplasia: A review

Pediatric Pulmonology

Volumn 42, Issue 10, 2007, Pages 952-961

  Bokodi, Géza ^a   Treszl, András ^a   Kovács, Lajos ^a   Tulassay, Tivadar ^a   Vásárhelyi, Barna ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Bronchopulmonary dysplasia; Cytokine; Genetic polymorphism; Low birth weight infant; Perinatal complications

Indexed keywords

ANGIOTENSIN; CELL ADHESION MOLECULE; CYTOKINE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 72; INTERLEUKIN 6; ISOLEUCINE; L SELECTIN; MANNAN BINDING LECTIN; MATRIX METALLOPROTEINASE; PROLINE; SERINE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; VALINE; VASCULOTROPIN;

ARTIFICIAL VENTILATION; BLOOD CLOTTING; BRAIN INJURY; CHORIOAMNIONITIS; DISABILITY; DISEASE PREDISPOSITION; FIBRINOLYSIS; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRON; LUNG CIRCULATION; LUNG DEVELOPMENT; LUNG DYSPLASIA; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESPIRATORY DISTRESS SYNDROME; REVIEW; VERY LOW BIRTH WEIGHT;

BRONCHOPULMONARY DYSPLASIA; CHORIOAMNIONITIS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; LUNG; POLYMORPHISM, GENETIC; PREGNANCY; RISK FACTORS; VENTILATORS, MECHANICAL;

EID: 35148876410     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20689     Document Type: Review

References (110)

1. Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet 2006;367:1421-1431.
2. Christou H, Brodsky D. Lung injury and bronchopulmonary dysplasia in newborn infants. J Intensive Care Med 2005;20:76-87.
3. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-1729.
4. Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, Jun JK. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999;181:773-779.
5. Parton LA, Strassberg SS, Qian D, Galvin-Parton PA, Cristea LA. The genetic basis for bronchopulmonary dysplasia. Front Biosci 2006;11:1854-1860.
6. Bhandari V, Bizzarro MJ, Shetty A, Zhong X, Page GP, Zhang H, Ment LR, Gruen JR, for the Neonatal Genetics Study Group. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006;117:1901-1906.
7. Bhandari V, Gruen JR. The genetics of bronchopulmonary dysplasia. Semin Perinatol 2006;30:185-191.
8. Derzbach L, Bokodi G, Treszl A, Vasarhelyi B, Nobilis A, Rigo J, Jr. Selectin polymorphisms and perinatal morbidity in low birth weight infants. Acta Paediatr 2006;95:1213-1217.
9. Li YH, Tullus K. Microbial infection and inflammation in the development of chronic lung disease of prematurity. Microbes Infect 2002;4:723-732.
10. Speer CP. Inflammation and bronchopulmonary dysplasia. Semin Neonatal 2003;8:29-38.
11. Speer CP. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med 2006;11:354-362.
12. De Dooy JJ, Mahieu LM, Van Bever HP. The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr 2001;160:457-463.
13. Dammann O, Leviton A, Gappa M, Dammann CE. Lung and brain damage in preterm newborns, and their association with gestational age, prematurity subgroup, infection/inflammation and long term outcome. BJOG 2005;112:4-9.
14. Speer CP. Newinsights into the pathogenesis of pulmonary inflammation in preterm infants. Biol Neonate 2001;79:205.
15. Kazzi SN, Kim UO, Quasney MW, Buhimschi I. Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants. Pediatrics 2004;114:e243-e248.
16. Bokodi G, Treszl A, Derzbach L, Balogh A, Vasarhelyi B. The association of the carrier state of the tumor necrosis factor-alpha (TNFalpha)-308A allele with the duration of oxygen supplementation in preterm neonates. Eur Cytokine Netw 2005;16:78-80.
17. Adcock K, Hedberg C, Loggins J, Kruger TE, Baier RJ. The TNF-alpha-308, MCP-1-2518 and TGF-beta1+915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants. Genes Immun 2003; 4:420-426.
18. Strassberg SS, Cristea IA, Qian D, Parton LA. Single nucleotide polymorphisms of tumor necrosis factor-alpha and the susceptibility to bronchopulmonary dysplasia. Pediatr Pulmonol 2007; 42:29-36.
19. Bokodi G, Derzbach L, Banyasz I, Tulassay T, Vasarhelyi B. The association of Interferon-Gamma T+874A and Interleukin-12 p40 promoter CTCTAA/GC polymorphism with the need for respiratory support and perinatal complications in low birth weight neonates. Arch Dis Child Fetal Neonatal Ed 2007;92:F25-F29.
20. Yanamandra K, Boggs P, Loggins J, Baier RJ. Interleukin-10-1082G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants. Pediatr Pulmonol 2005;39:426-432.
21. Asikainen TM, White CW. Antioxidant defense in the preterm lung: role for hypoxia-inducible factors in BPD? Toxicol Appl Pharmacol 2005;203:177-188.
22. Manar MH, Brown MR, Gauthier TW, Brown LA. Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia. J Perinatol 2004;24:30-35.
23. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S, Egido J. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl 2002;82:12-22.
24. Guba M, Steinbauer M, Buchner M, Frolich D, Farkas S, Jauch KW, Anthuber M. Differential effects of short-term ace-and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro. Shock 2000;13:190-196.
25. Kazzi SN, Quasney M. Deletion allele of angiotensin-converting enzyme is associated with increased risk and severity of bronchopulmonary dysplasia. J Pediatr 2005;147:818-822.
26. Bokodi G, Derzbach L, Vasarhelyi B. Re: deletion allele of angiotensin-converting enzyme. J Pediatr 2006;149:579.
27. Lin HC, Su BH, Lin TW, Hsu CM, Wan L, Tsai CH, Tsai FJ. No association of urokinase gene 3′-UTR polymorphism with bronchopulmonary dysplasia for ventilated preterm infants. Acta Paediatr Taiwan 2004;45:315-319.
28. Hallman M, Haataja R. Genetic influences and neonatal lung disease. Semin Neonatal 2003;8:19-27.
29. Alexander JM, McIntire DM, Leveno KJ. Chorioamnionitis and the prognosis for term infants. Obstet Gynecol 1999;94:274-278.
30. Andrews WW, Hauth JC, Goldenberg RL. Infection and preterm birth. Am J Perinatol 2000;17:357-365.
31. Bracci R, Buonocore G. Chorioamnionitis: a risk factor for fetal and neonatal morbidity. Biol Neonate 2003;83:85-96.
32. Arias F, Victoria A, Cho K, Kraus F. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol 1997;89:265-271.
33. Dexter SC, Malee MP, Pinar H, Hogan JW, Carpenter MW, Vohr BR. Influence of chorioamnionitis on developmental outcome in very low birth weight infants. Obstet Gynecol 1999;94:267-273.
34. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194-202.
35. Chaiworapongsa T, Romero R, Kim JC, Kim YM, Blackwell SC, Yoon BH, Gomez R. Evidence for fetal involvement in the pathologic process of clinical chorioamnionitis. Am J Obstet Gynecol 2002;186:1178-1182.
36. Saji F, Samejima Y, Kamiura S, Sawai K, Shimoya K, Kimura T. Cytokine production in chorioamnionitis. J Reprod Immunol 2000;47:185-196.
37. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998;179:186-193.
38. Amory JH, Adams KM, Lin MT, Hansen JA, Eschenbach DA, Hitti J. Adverse outcomes after preterm labor are associated with tumor necrosis factor-alpha polymorphism -863, but not -308, in mother-infant pairs. Am J Obstet Gynecol 2004;191:1362-1367.
39. Park JS, Romero R, Yoon BH, Moon JB, Oh SY, Han SY, Ko EM. The relationship between amniotic fluid matrix metalloproteinase-8 and funisitis. Am J Obstet Gynecol 2001;185:1156-1161.
40. Jobe AH. Antenatal associations with lung maturation and infection. J Perinatol 2005;25:S31-S35.
41. Babbage SJ, Arkwright PD, Vince GS, Perrey C, Pravica V, Quenby S, Bates M, Hutchinson IV. Cytokine promoter gene polymorphisms and idiopathic recurrent pregnancy loss. J Reprod Immunol 2001;51:21-27.
42. Baxter N, Sumiya M, Cheng S, Erlich H, Regan L, Simons A, Summerfield JA. Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes. Clin Exp Immunol 2001;126:529-534.
43. Karhukorpi J, Laitinen T, Karttunen R, Tiilikainen AS. The functionally important IL-10 promoter polymorphism (-1082G->A) is not a major genetic regulator in recurrent spontaneous abortions. Mol Hum Reprod 2001;7:201-203.
44. Reid JG, Simpson NA, Walker RG, Economidou O, Shillito J, Gooi HC, Duffy SR, Walker JJ. The carriage of proinflammatory cytokine gene polymorphisms in recurrent pregnancy loss. Am J Reprod Immunol 2001;45:35-40.
45. Daher S, Shulzhenko N, Morgun A, Mattar R, Rampim GF, Camano L, DeLima MG. Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol 2003;58:69-77.
46. Costeas PA, Koumouli A, Giantsiou-Kyriakou A, Papaloizou A, Koumas L. Th2/Th3 cytokine genotypes are associated with pregnancy loss. Hum Immunol 2004;65:135-141.
47. Hefler LA, Tempfer CB, Bashford MT, Unfried G, Zeillinger R, Schneeberger C, Koelbl H, Nagele F, Huber JC. Polymorphisms of the angiotensinogen gene, the endothelial nitric oxide synthase gene, and the interleukin-1beta gene promoter in women with idiopathic recurrent miscarriage. Mol Hum Reprod 2002;8:95-100.
48. Unfried G, Tempfer C, Schneeberger C, Widmar B, Nagele F, Huber JC. Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril 2001;75:683-687.
49. Simhan HN, Krohn MA, Roberts JM, Zeevi A, Caritis SN. Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. Am J Obstet Gynecol 2003;189:915-918.
50. Hartel Ch, Finas D, Ahrens P, Kattner E, Schaible T, Muller D, Segerer H, Albrecht K, Moller J, Diedrich K, Gopel W, Genetic Factors in Neonatology Study Group. Polymorphisms of genes involved in innate immunity: association with preterm delivery. Mol Hum Reprod 2004;10:911-915.
51. Genc MR, Onderdonk AB, Vardhana S, Delaney ML, Norwitz ER, Tuomala RE, Paraskevas LR, Wifkin SS, MAP Study Group. Polymorphism in intron 2 of the interleukin-1 receptor antagonist gene, local midtrimester cytokine response to vaginal flora, and subsequent preterm birth. Am J Obstet Gynecol 2004;191:1324-1330.
52. Dizon-Townson DS, Major H, Varner M, Ward K. A promoter mutation that increases transcription of the tumor necrosis factor-alpha gene is not associated with preterm delivery. Am J Obstet Gynecol 1997;177:810-813.
53. Simhan HN, Krohn MA, Zeevi A, Daftary A, Harger G, Caritis SN. Tumor necrosis factor-alpha promoter gene polymorphism - 308 and chorioamnionitis. Obstet Gynecol 2003;102:162-166.
54. Roberts AK, Monzon-Bordonaba F, Van Deerlin PG, Holder J, Macones GA, Morgan MA, Strauss JF, Parry S. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol 1999;180:1297-1302.
55. Annells MF, Hart PH, Mullighan CG, Heatley SL, Robinson JS, Bardy P, McDonald HM. Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: risk of preterm birth. Am J Obstet Gynecol 2004;191: 2056-2067.
56. Witkin SS, Vardhana S, Yih M, Doh K, Bongiovanni AM, Gerber S. Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1 beta and interleukin-1 receptor antagonist and pregnancy outcome. Am J Obstet Gynecol 2003;189:1413-1417.
57. Genc MR, Gerber S, Nesin M, Witkin SS. Polymorphism in the interleukin-1 gene complex and spontaneous preterm delivery. Am J Obstet Gynecol 2002;187:157-163.
58. Bessler H, Osovsky M, Sirota L. Association between IL-1ra gene polymorphism and premature delivery. Biol Neonate 2004;85:179-183.
59. Kalish RB, Vardhana S, Gupta M, Chasen ST, Perni SC, Witkin SS. Interleukin-1 receptor antagonist gene polymorphism and multifetal pregnancy outcome. Am J Obstet Gynecol 2003;189:911-914.
60. Kalish RB, Vardhana S, Gupta M, Perni SC, Witkin SS. Interleukin-4 and -10 gene polymorphisms and spontaneous preterm birth in multifetal gestations. Am J Obstet Gynecol 2004;190:702-706.
61. Wang H, Parry S, Macones G, Sammel MD, Ferrand PE, Kuivaniemi H, Tromp G, Halder I, Shriver MD, Romero R, Strauss JF III. Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM). Hum Mol Genet 2004;13:2659-2669.
62. Ferrand PE, Parry S, Sammel M, Macones GA, Kuivaniemi H, Romero R, Strauss JF III. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 2002;8:494-501.
63. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-1433.
64. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-145.
65. Inohara N, Ogura Y, Chen FF, Muto A, Nunez G. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem 2001;276:2551-2554.
66. Inohara N, Ogura Y, Nunez G. Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr Opin Microbiol 2002;5:76-80.
67. Lorenz E, Hallman M, Marttila R, Haataja R, Schwartz DA. Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res 2002;52:373-376.
68. Szebeni B, Szekeres R, Rusai K, Vannay A, Veres G, Treszl A, Arato A, Tulassay T, Vasarhelyi B. Genetic polymorphisms of CD14, toll-like receptor 4, and caspase-recruitment domain 15 are not associated with necrotizing enterocolitis in very low birth weight infants. J Pediatr Gastroenterol Nutr 2006;42:27-31.
69. Bodamer OA, Mitterer G, Maurer W, Pollak A, Mueller MW, Schmidt WM. Evidence for an association between mannose-binding lectin 2 (MBL2) gene polymorphisms and pre-term birth. Genet Med 2006;8:518-524.
70. Frakking FN, Brouwer N, Zweers D, Merkus MP, Kuijpers TW, Offringa M, Dolman KM. High prevalence of mannose-binding lectin (MBL) deficiency in premature neonates. Clin Exp Immunol 2006;145:5-12.
71. Annells MF, Hart PH, Mullighan CG, Heatley SL, Robinson JS, Bardy P, McDonald HM. Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: risk of preterm birth. Am J Obstet Gynecol 2004;191:2056-2067.
72. Nesin M. Genetic basis of preterm birth. Front Biosci 2007;12:115-124.
73. Chappell S, Morgan L. Searching for genetic clues to the causes of pre-eclampsia. Clin Sci (Lond) 2006;110:443-458.
74. Broughton Pipkin F. What is the place of genetics in the pathogenesis of pre-eclampsia. Biol Neonate 1999;76:325-330.
75. Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, Greaves M, Vickers MA. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 2002;87:779-785.
76. Fatini C, Sticchi E, Gensini F, Genuardi M, Tondi F, Gensini GF, Riviello C, Parretti E, Mello G, Abbate R. Endothelial nitric oxyde synthase gene influences the risk of pre-eclampsia, the recurrence of negative pregnancy events, and the maternal-fetal flow. J Hypertens 2006;24:1823-1829.
77. Banyasz I, Szabo S, Bokodi G, Vannay A, Vasarhelyi B, Szabo A, Tulassay T, Rigo J, Jr. Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia. Mol Hum Reprod 2006;12:233-236.
78. Zoban P, Cerny M. Immature lung and acute lung injury. Physiol Res 2003;52:507-516.
79. Jobe AH, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev 1998;53:81-94.
80. Cole FS, Hamvas A, Nogee LM. Genetic disorders of neonatal respiratory function. Pediatr Res 2001;50:157-162.
81. Hallman M, Haataja R, Marttila R. Surfactant proteins and genetic predisposition to respiratory distress syndrome. Semin Perinatol 2002;26:450-460.
82. Kishore U, Bernal AL, Kamran MF, Saxena S, Singh M, Sarma PU, Madan T, Chakraborty T. Surfactant proteins SP-A and SP-D in human health and disease. Arch Immunol Ther Exp (Warsz) 2005;53:399-417.
83. Jeffrey A, Whitsett SE, Wert YX. Genetic disorders of surfactant homeostasis. Biol Neonate 2005;87:283-287.
84. Weber B, Borkhardt A, Stoll-Becker S, Reiss I, Gortner L. Polymorphisms of surfactant protein A genes and the risk of bronchopulmonary dysplasia in preterm infants. Turk J Pediatr 2000;42:181-185.
85. Makri V, Hospes B, Stoll-Becker S, Borkhardt A, Gortner L. Polymorphisms of surfactant protein B encoding gene: modifiers of the course of neonatal respiratory distress syndrome? Eur J Pediatr 2002;161:604-608.
86. Rova M, Haataja R, Marttila R, Ollikainen V, Tammela O, Hallman M. Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia. Hum Mol Genet 2004;13:1095-1104.
87. Lahti M, Marttila R, Hallman M. Surfactant protein C gene variation in the Finnish population - association with perinatal respiratory disease. Eur J Hum Genet 2004;12:312-320.
88. Haataja R, Marttila R, Uimari P, Lofgren J, Ramet M, Hallman M. Respiratory distress syndrome: evaluation of genetic susceptibility and protection by transmission disequilibrium test. Hum Genet 2001;109:351-355.
89. Haataja R, Ramet M, Marttila R, Hallman M. Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum Mol Genet 2000;9:2751-2760.
90. Marttila R, Haataja R, Ramet M, Lofgren J, Hallman M. Surfactant protein B polymorphism and respiratory distress syndrome in premature twins. Hum Genet 2003;112:18-23. [Epub 2002 Oct 10].
91. Bland RD. Neonatal chronic lung disease in the post-surfactant era. Biol Neonate 2005;88:181-191.
92. Fekete A, Treszl A, Toth-Heyn P, Vannay A, Tordai A, Tulassay T, Vasarhelyi B. Association between heat shock protein 72 gene polymorphism and acute renal failure in premature neonates. Pediatr Res 2003;54:452-455.
93. Stenmark KR, Abman SH. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol 2005;67:623-661.
94. Whitsett JA, Wert SE, Trapnell BC. Genetic disorders influencing lung formation and function at birth. Hum Mol Genet 2004;13: Spec No 2 R207-R215.
95. Balogh A, Treszl A, Vannay A, Vasarhelyi B. A prevalent functional polymorphism of insulin-like growth factor system is not associated with perinatal complications in preterm infants. Pediatrics 2006;117:591-592.
96. Bányász I, Bokodi G, Vásárhelyi B, Treszl A, Derzbach L, Szabó A, Tulassay T, Vannay Á. Genetic polymorphisms of vascular endothelial growth factor in perinatal complication. Eur Cytokine Netw 2006;17:266-270.
97. Treszl A, Kocsis I, Szathmari M, Schuler A, Heninger E, Tulassay T, Vasarhelyi B. Genetic variants of TNF-[FC12]a, IL-1beta, IL-4 receptor [FC12]a-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biol Neonate 2003;83:241-245.
98. Ahrens P, Kattner E, Kohler B, Hartel C, Seidenberg J, Segerer H, Moller J, Gopel W, Genetic Factors in Neonatology Study Group. Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants. Pediatr Res 2004;55:652-656.
99. Hedberg CL, Adcock K, Martin J, Loggins J, Kruger TE, Baier RJ. Tumor necrosis factor alpha -308 polymorphism associated with increased sepsis mortality in ventilated very low birth weight infants. Pediatr Infect Dis J 2004;23:424-428.
100. Harding D, Dhamrait S, Millar A, Humphries S, Marlow N, Whitelaw A, Montgomery H. Is interleukin-6-174 genotype associated with the development of septicemia in preterm infants? Pediatrics 2003;112:800-803.
101. Baier RJ, Loggins J, Yanamandra K. IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants. BMC Med 2006;4:10.
102. Treszl A, Heninger E, Kaiman A, Schuler A, Tulassay T, Vasarhelyi B. Lower prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis. J Pediatr Surg 2003;38:1374-1378.
103. Treszl A, Kocsis I, Szathmari M, Schuler A, Tulassay T, Vasarhelyi B. Genetic variants of the tumour necrosis factor-alpha promoter gene do not influence the development of necrotizing enterocolitis. Acta Paediatr 2001;90:1182-1185.
104. Treszl A, Tulassay T, Vasarhelyi B. Genetic basis for necrotizing enterocolitis - risk factors and their relations to genetic polymorphisms. Front Biosci 2006;11:570-580.
105. Heninger E, Treszl A, Kocsis I, Derfalvi B, Tulassay T, Vasarhelyi B. Genetic variants of the interleukin-18 promoter region (-607) influence the course of necrotising enterocolitis in very low birth weight neonates. Eur J Pediatr 2002;161:410-411.
106. Harding D, Dhamrait S, Marlow N, Whitelaw A, Gupta S, Humphries S, Montgomery H. Angiotensin-converting enzyme DD genotype is associated with worse perinatal cardiorespiratory adaptation in preterm infants. J Pediatr 2003;143:746-749.
107. Nobilis A, Szabo M, Kocsis I, Sulyok E, Tulassay T, Vasarhelyi B. Angiotensin-converting enzyme DD genotype is preventive against circulatory failure in very-low-birthweight neonates. Acta Paediatr 2006;95:747-750.
108. Treszl A, Szabo M, Dunai Gy, Nobilis A, Machay T, Tulassay T, Vásárhelyi B. Angiotensin II type 1 receptor A1166C polymorphism and prophylactic indomethacin treatment induced ductus arteriosus (DA) closure in very low birth weight neonates. Ped Res 2003;54:753-755.
109. Derzbach L, Treszl A, Balogh A, Vasarhelyi B, Tulassay T, Rigo JJ. Gender dependent association between perinatal morbidity and estrogen receptor-alpha Pvull polymorphism. J Perinat Med 2005;33:461-462.
110. Baier RJ. Genetics of perinatal brain injury in the preterm infant. Front Biosci 2006;11:1371-1387.